Managing Expectations: Adverse Events With Melanoma Immunotherapy

Source: Cancer Network, May 2025

Toxicity Profiles of Immunotherapy Regimens

Key Discussion Points:

  • Immunotherapy regimens share similar categories of adverse events but differ significantly in frequency and severity
  • Patient education and preparation for toxicity management are critical components of immunotherapy administration
  • Specific toxicities are more commonly associated with certain regimens

Key Points for Physicians:

  • Common immune-related adverse events across regimens include cutaneous reactions, colitis, hepatitis, and endocrinopathies, with severity rates varying by regimen.

READ THE FULL ARTICLE 

You must be logged in to post a comment.
Menu